Nucleotide receptors: An emerging family of regulatory molecules in blood cells

Blood

Volumn 97, Issue 3, 2001, Pages 587-600

  Di Virgilio, Francesco ^a   Chiozzi, Paola ^a   Ferrari, Davide ^a   Falzoni, Simonetta ^a   Sanz, Juana M ^a   Morelli, Anna ^a   Torboli, Maurizia ^a   Bolognesi, Giorgio ^a   Baricordi, O Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTOKINE; MEMBRANE RECEPTOR; NUCLEOTIDE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; REACTIVE OXYGEN METABOLITE; RECEPTOR SUBTYPE;

ARTICLE; BLOOD CELL; BLOOD VESSEL INJURY; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CHEMOTAXIS; CYTOKINE RELEASE; DENDRITIC CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; LYSOSOME; MACROPHAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0035253835     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.3.587     Document Type: Article

References (236)

1. A basis for distinguishing two types of purinergic receptors
2. Receptors for purines and pyrimidines
3. Purinoceptors: Are there families of P2X and P2Y purinoceptors?
4. Extracellular ATP: Effects, sources and fate
5. Distribution of P2Y receptor subtypes on hematopoietic cells
6. The past, present and future of purine nucleotides as signalling molecules
7. Extracellular ATP in T-lymphocyte activation: Possible role in effector functions
8. ATP and gap junction-dependent intercellular calcium signalling in osteoblastic cells
9. Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin
10. A release mechanism for stored ATP in ocular ciliary epithelial cells
11. Connexins regulate calcium signalling by controlling ATP release
12. Cystic fibrosis transmembrane conductance regulator-associated ATP release is controlled by a chloride sensor
13. Determination of ATP and ADP in blood platelets
14. Comparative study of platelet dense granule constituents
15. Identification and characterization of CD39 vascular ATP diphosphohydrolase
16. 2+)-apyrase
17. Ecto-nucleotidases: Molecular structures, catalytic properties and functional roles in the nervous system
18. Immunolocalization of ATP diphosphohydrolase in pig and mouse brains and sensory organs of the mouse
19. Ectoprotein kinases: Ecto-domain phosphorylation as a novel target for pharmacological manipulation?
20. Signal transduction by P2-purinergic receptors for extracellular ATP
21. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides
22. The P2Z purinoceptor: An intriguing role in immunity, inflammation and cell death
23. Purines and neutrophil leukocytes
24. Cytolytic P2X purinoceptors
25. P2 receptor subtypes in the cardiovascular system
26. P2T purinoceptors: ADP receptors on platelets
27. Is there a basis for distinguishing two types of P2-purinoceptor?
28. G proteincoupled receptors for ATP and other nucleotides: A new receptor family
29. Families of ion channels with two hydrophobic segments
30. Expression cloning of an ATP receptor from mouse neuroblastoma cells
31. Cloning and functional expression of a brain G-proteincoupled ATP receptor
32. 4 receptor
33. Cloned and transfected P2Y4 receptors: Characterization of suramin and PPADS-insensitive response to UTP
34. Molecular cloning and functional analysis of a novel P2 nucleotide receptor
35. 6 receptor
36. Cloning and characterization of a bovine P2Y receptor
37. 1 purinoceptor
38. Cloning of a human purinergic P2Y receptor coupled to phospholipase and adenylyl cyclase
39. Stimulation of phosphatidate synthesis in endothelial cells in response to P2-receptor activation. Evidence for phospholipase C and phospholipase D involvement, phosphatidate and diacylglycerol interconversion and the role of protein kinase C
40. Suramin: A reversible P2-purinoceptor antagonist in the mouse vas deferens
41. Identification of competitive antagonists of the P2Y1 receptor
42. 1 receptor antagonists
43. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor
44. A new class of ligand-gated ion channels defined by P2X receptor for extracellular ATP
45. P2X receptors: An emerging channel family
46. Cloned ligand-gated channels activated by extracellular ATP (P2X receptors)
47. 7)
48. 7 receptor
49. 7 receptor: A pivotal role in inflammation and immunomodulation
50. Co-expression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons
51. 3 form stable trimers: A novel structural motif of ligand-gated ion channels
52. P2X receptors
53. Distribution of P2X receptors in the rat adrenal gland
54. 7 receptor function with a monoclonal antibody
55. A P2X purinoceptor expressed by a subset of sensory neurons
56. Contribution of P2-purinoceptors to neurogenic contraction of rat urinary bladder smooth muscle
57. ATP induces nucleotide permeability in rat mast cells
58. 4- receptor of rat mast cells
59. 4- promotes cation fluxes in the J774 mouse macrophage cell line
60. Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel
61. 7. Cloning and expression of a human cDNA
62. 2 purinoceptor classification
63. 2z receptor
64. Phosphorylation of T-lymphocyte plasma membrane-associated proteins by ectoprotein kinases: Implications for a possible role for ectophosphorylation in T-cell effector functions
65. The purinergic P2Z receptor of human macrophage cells: Characterization and possible physiological role
66. The P2Z-purinoceptor of human lymphocytes: Actions of nucleotide agonists and irreversible inhibition by oxidized ATP
67. 7 receptors
68. 7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release
69. The isoquinoline derivative KN-62: A potent antagonist of the P2Z-receptor of human lymphocytes
70. Purification and characterization of calcium-calmodulin kinase II from human parathyroid glands
71. Role of extracellular adenosine triphosphate in the cytotoxic T lymphocyte-mediated lysis of antigen presenting cells
72. 7 nucleotide receptor: High selectivity for the human versus rat receptor homologues
73. 7 receptors
74. 4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes
75. 2+ fluxes in J774 macrophages by two distinct mechanisms
76. 7 receptor
77. ATP-mediated cytotoxicity in microglial cells
78. 2+ levels
79. ATP-activated inward currents and calcium-permeable channels in rat macrophage plasma membranes
80. Pyrimidinoceptor-mediated activation of phospholipase C and phospholipase A2 in RAW 264.7 macrophages
81. Modulation of phagocytosis by P2-purinergic receptors in mouse peritoneal macrophages
82. A novel pathway for the activation of phospholipase D by P2Z purinergic receptors in BAC1.2F5 macrophages
83. P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages
84. Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages
85. Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells
86. Towards a revised nomenclature for P1 and P2 receptors
87. γ, in the human THP-1 monocytic cell line
88. Expression of multiple ATP receptor subtypes during the differentiation and inflammatory activation of myeloid leukocytes
89. Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators
90. The regulation of pinocytosis in mouse macrophages, III: The induction of vesicle formation by nucleosides and nucleotides
91. 2+]i, and inhibits phagocytosis in mouse macrophages
92. Extracellular ATP induces a large nonselective conductance in macrophage plasma membranes
93. Calcium responses elicited by nucleotides in macrophages. Interaction between two receptor subtypes
94. Characterization of the cytotoxic effect of extracellular ATP in J774 mouse macrophages
95. Chemotaxis of rat mast cells toward adenine nucleotides
96. 2+ response mediated by P2U and P2Y purinoceptors in human macrophages: Signalling from dying cells to macrophages
97. + channel
98. Extracellular ATP enhances mRNA levels of nitric oxice synthase and TNFα in lipopolysaccharide-treated RAW 264.7 murine macrophages
99. Release of IL-1 from mononuclear phagocytes
100. IL-1β maturation: Evidence that mature cytokine formation can be induced specifically by nigericin
101. Interleukin 1 is processed and released during apoptosis
102. Biochemical pathways of caspase activation during apoptosis
103. Interleukin-1β maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity
104. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP
105. Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells
106. Increased mature interleukin-1β secretion from THP-1 cells induced by nigericin is a result of activation of p45 IL-1β-converting enzyme processing
107. Post-translational processing of murine IL-1: Evidence that ATP-in duced release of IL-1α and IL-1β occurs via a similar mechanism
108. Mice deficient in IL-1β-convering enzyme are defective in production of mature IL-1β and resistant to endotoxic shock
109. Extracellular ATP activates transcription factor NF-κB through the P2Z purinoceptor by selectively targeting NF-κB p65
110. Plasma membrane potential in thymocyte apoptosis
111. ATP treatment of human monocytes promotes caspase-1 maturation and externalization
112. The secretory route of the leaderless protein interleukin 1β involved exocytosis of the endolysosome-related vesicles
113. 7 receptors
114. Protection of mice from endotoxic death by 2-methylthio-ATP
115. Purinergic receptor modulation of lipopolysaccharide signalling and inducible nitric-oxide synthase expression in Raw 264.7 macrophages
116. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium
117. Extracellular ATP potentiates nitric oxide synthase expression induced by lipopolysaccharide in RAW 264.7 murine macrophages
118. 7- independent mechanism
119. The biological relevance of polykarions in the immune response
120. Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-γ and IL-4
121. ATP receptors and giant cell formation
122. 7 receptor and polykarion formation
123. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin
124. 7 receptors
125. ATP-induced killing of virulent Mycobacteriurn tuberculosis within human macrophages requires phospholipase D
126. Effects of extracellular ATP on mononuclear phagocytes
127. A cation non-selective channel induced by extracellular ATP in macrophages and phagocytic cells of the thymic reticulum
128. Dissociation of the pore-forming and phospholipase D activities stimulated via P2Z purinergic receptors in BAC1.2F5 macrophages. Product inhibition of phospholipase D enzyme activity
129. 7 nucleotide receptor expression by pro- and antiinflammatory stimuii in THP-1 monocytes
130. Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures
131. Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation
132. P2Z purinoceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death
133. 7/P2Z purinoceptor-mediated activation of transcription factor NFAT in microglial cells
134. Rodent epidermal Langerhans cells demonstrate greater histochemical specificity for ADP than for ATP and AMP
135. Epidermal Langerhans cells are resistant to the permeabilizing effects of extracellular ATP in vitro evidence supporting a protective role of membrane ATPase
136. Characterization of P2Z purinergic receptors on phagocytic cells of the thymic reticulum in culture
137. Extracellular ATP: A further modulator in neuroendocrine control of the thymus
138. Expression and a role of functionally coupled P2Y receptors in human dendritic cells
139. Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ectonucleotidases
140. 7 purinergic receptor: Characterization and possible participation in antigen presentation
141. The P2 purinergic receptors of human dendritic cells: Identification and coupling to cytokine release
142. 7 receptor characterized in murine dendritic cells: Role on the induction of apoptosis
143. Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells
144. 7 receptor-dependent apoptosis of dendritic cells
145. Adenosine and adenine nucleotides are mitogenic for mouse thymocytes
146. Selective suppression of blastogenesis induced by different mitogens: Effect of noncyclic adenosine-containing compounds
147. Adenosine 5′-triphosphate (ATP)-mediated stimulation and suppression of DNA synthesis in lymphoid cells, I: Characterization of ATP responsive cells in mouse lymphoid organs
148. Inhibition of human natural killer cell reactivity by exogenous adenosine 5′-triphosphate
149. Exogenous ATP enhances calcium influx in intact thymocytes
150. Extracellular ATP increases cytosolic free calcium in thymocytes and initiates the blastogenesis of the phorbol 12-myristate 13-acetate-treated medullary population
151. i increase induced in murine thymocytes by extracellular ATP does not involve ATP hydrolysis and is not related to phosphoinositicle metabolism
152. Extracellular ATP induces a non-specific permeability of thymocyte plasma membranes
153. Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes
154. Responses of mouse lymphocytes to extracellular adenosine 5′-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effect of ATP
155. Ecto-ATPase activity in cytolytic T lymphocytes. Protection from the cytolytic effects of extracellular ATP
156. Extracellular ATP as a possible mediator of cell-mediated cytotoxicity
157. 2-purinoceptors
158. + uptake: Inhibition of fluxes by suramin
159. Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients
160. Purinoceptor-operated cationic channels in human B-lymphocytes
161. 7 channel
162. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes
163. 1, in thymocyte apoptosis
164. Effects of extracellular ATP and adenosine on different thymocyte subsets. Possible role of ATP-gated channels and G protein-coupled purinergic receptor
165. Murine T lymphocytes modulate activity of an ATP-activated P2Z-type purinoceptor during differentiation
166. Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes
167. Dynamics of ATP-induced calcium signalling in single mouse thymocytes
168. Extracellular ATP as a trigger for apoptosis or programmed cell death
169. Cell-mediated cytotoxicity: ATp as an effector and the role of target cells
170. Role of extracellular ATP in cell-mediated cytotoxicity: A study with ATP-sensitive and ATP-resistant macrophages
171. 7 ATP receptor
172. Extracellular ATP causes loss of L-selectin from human lymphocytes via occupancy of P2Z purinoceptors
173. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases
174. Phospholipid metabolism and lysosomal enzyme secretion by leukocytes. Effects of dibutyryl cyclic adenosine 3′:5′-monophosphate and ATP
175. Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin 12 production, adenine nucleotide release, and responses to vasoactive agents
176. 2- responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotides
177. Regulatory effects of adenosine and adenine nucleotides on oxygen radical responses of neutrophils
178. Extracellular ATP triggers superoxide production in human neutrophils
179. ATP-induced calcium mobilization in human neutrophils
180. Activation of inositol phospholipid-specific phospholipase C by P2-purinergic receptors in human phagocytic leukocytes: Role of pertussis toxin-sensitive G proteins
181. ATP stimulates secretion in human neutrophils and HL60 cells via a pertussis toxin-sensitive guanine nucleotide-binding protein coupled to phospholipase C
182. Extracellular adenosine nucleotides stimulate protein kinase C activity and human neutrophil activation
183. P2-purinergic receptors activate a guanine nucleotide-dependent phospholipase C in membranes from HL-60 cells
184. Stimulation of human neutrophil adhesive properties by adenine nucleotides
185. Loss of ATP diphosphohydrolase activity with endothelial cell activation
186. Extracellular nucleotides stimulate leukocyte adherence to cultured pulmonary artery endothelial cells
187. Nucleotide-induced PMN adhesion to cultured epithelial cells: Possible role of MUC1 mucin
188. Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: Adenosine dependent and independent mechanisms
189. Involvement of ecto-ATPase and extracellular ATP in polymorphonuclear granulocyte-endithelial interactions
190. Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines
191. Stage-specific expression of P2Y receptors, ecto-apyrase and ecto-5′-nucleotidase in myeloid leukocytes
192. 2+ mobilization in human neutrophils via a pertussis toxin sensitive G-protein
193. Extracellular ATP stimulates interleukin-dependent cultured mast cell and eosinophils through calcium mobilization
194. 2+ mobilization and actin reorganization in human neutrophils
195. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets
196. Aggregation of blood platelets by adenosine diphosphate and its reversal
197. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man
198. Activation of ADP receptors and platelet function
199. Receptors for ADP of human blood platelets
200. ADP receptors on platelets
201. 2+ in the suspending medium On the responses of human and rabbit platelets to aggregating agents
202. Adenosine diphosphate (ADP)-induced alpha granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole
203. 2T purinoceptors in human platelets
204. 1 purinoceptors in human platelets and megakarioblastic cell lines
205. 1 purinoceptor in human platelets
206. 1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes
207. 1 receptor is an ADP receptor antagonized by ATP and expressed in platelets amd megakarioblastic cells
208. 1 purinoceptor in ADP-induced platelet activation
209. Molecular basis for ADP-induced platelet activation, I: Evidence for three distinct ADP receptors on human platelets
210. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5-diphosphate (ADP) in human platelets
211. Pharmacology of the platelet ADP receptors: Agonist and antagonist
212. 1-deficient mice
213. 1 receptors
214. ADP receptors and clinical bleeding disorders
215. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation
216. Platelet P2 receptors: From curiosity to clinical targets
217. Secreted dense granule adenine nucleotides promote calcium influx and the maintenance of elevated cytosolic calcium levels in stimulated human platelets
218. 2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis
219. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
220. Influence of external ATP on permeability and metabolism of dog red blood cells
221. A proposal for the role of ecto-enzymes and adenylates in traumatic shock
222. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia
223. Phosphatidylinositol 4,5-bisphosphate hydrolysis in turkey erythrocytes is regulated by P2Y purinoceptors
224. Kinetics of activation of phospholipase C by P2 purinergic agonists and guanine nucleotides
225. P2 purinoceptors on vascular endothelial cells: Physiological significance and transduction mechanisms
226. The regulation of vascular function by P2 receptors: Multiple sites and multiple receptors
227. Removal of hematopoietic cells and macrophages from mouse bone marrow cultures: Isolation of fibroblast-like stromal cells
228. Extracellular adenosine triphosphate: A shock to hemopoietic cells
229. Cell-to-cell calcium signals mediated by ATP receptors in mast cells
230. + channels through multiple G protein-linked receptors
231. 1 receptor activation in HL-60 cells
232. ATP acts as an agonist to promote stimulus-induced secretion of IL-1β and IL-18 in human blood
233. ATP stimulated release of IL-1β and IL-18 requires priming by LPS and is independent of caspase-1 cleavage
234. Extracellular ATP and TNF-α synergize in the activation of human dendritic cells
235. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate T-helper 1 responses